Reference ranges are not goals
When a lab returns a result inside the reference range, it is telling you one thing: ninety-five percent of the apparently healthy population it sampled fell within these two numbers. That is a useful starting point. It is not a target.
Reference ranges are built from large, mostly older, mostly sedentary cohorts. They describe statistical normality, not biological optimum. A free testosterone in the 'normal' bottom decile for a thirty-year-old man is not optimum even though the lab will flag it green.
Context beats individual values
No single marker tells the whole story. Free testosterone without SHBG and albumin is a number without a denominator. LDL-C without ApoB and Lp(a) is a partial picture. HbA1c without fasting glucose and insulin can flag late, after dysfunction is already entrenched.
Good interpretation means triangulating across markers and across time. We trend everything. A single draw is a snapshot; three draws ninety days apart is a movie.
What changes, and how fast
Some markers move within weeks: fasting insulin, hs-CRP, ferritin, free T3. Others lag months: HbA1c is a ninety-day average, lipid changes from real intervention often take twelve weeks to manifest, IGF-1 plateaus around six weeks after a GH-axis change.
Do not panic over a number that hasn't had time to move. Do not celebrate one either. Wait for the second draw.
Panels we order
The standard Nexphoria longitudinal panel includes: CBC with differential, comprehensive metabolic panel, full lipid panel including ApoB and Lp(a), HbA1c, fasting insulin, hs-CRP, ferritin, vitamin D, full thyroid (TSH, fT3, fT4, reverse T3), and a sex-specific hormone panel.
For patients on growth-hormone-axis peptides, we add IGF-1 and IGFBP-3. For metabolic patients, we add fasting C-peptide. For longevity protocols, we layer in homocysteine, methylmalonic acid, and uric acid.
Share
References
- [1]Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. Link